Experts speaking at the ADA’s Scientific Sessions supported making CGMs more accessible, but debated their usefulness for ...

Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

Medically reviewed by Patricia Mikula, PharmD Like other medicines and food, vitamins often have an expiration date. Vitamins ...

SINGAPORE - Drugs not only work differently on different people, but they could also have different effects on the same ...

Researchers in France have developed an antibody that blocks AMH, reversing PCOS symptoms in mice and opening the door to future human trials.

The annual meeting of the American Diabetes Association was held this year from June 20 to 23 in Chicago, drawing more than ...

The Semaglutide market is projected to expand from US$ 27.15 billion in 2024 to US$ 61.7 billion by 2033, with a CAGR of 9.55% from 2025. Driven by r ...

The first report by a presidential commission to “Make America Healthy Again (MAHA)” raises concerns about rising rates of ...

Vertex Pharmaceuticals Incorporated presented updated clinical data for zimislecel – VX-880) – its investigational stem ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

A clinical trial led by an Indiana University School of Medicine researcher found that weekly doses of semaglutide - a ...